BACKGROUND. New prognostic factors are needed to guide the treatment of patients with non-small-cell lung cancer. We evaluated the prognostic value of altered expression of ABH blood-group antigens, which has been implicated in the multistep process of carcinogenesis and tumor progression. METHODS. The presence of blood-group antigens was assessed immunohistochemically in paraffin-embedded tumor samples from 164 patients who underwent curative surgery for non-small-cell lung cancer from 1980 through 1982. Monoclonal antibodies were used to detect the A and B antigens, and Ulex europaeus agglutinin I to detect H antigen. RESULTS. Survival of the 28 patients with blood type A or AB who had primary tumors negative for blood-group antigen A was significantly shorter than that of the 43 patients with antigen A-positive tumors (P less than 0.001) and of the 93 patients with blood type B or O (P = 0.002). The respective median survival times were 15, 71, and 39 months. Disease progressed significantly earlier in the 28 patients with tumors negative for blood-group antigen A than in the antigen A-positive patients (P less than 0.001). Expression of blood-group antigen B or H in tumor cells did not correlate with survival. Cox proportional-hazards regression analysis showed that expression of blood-group antigen A in tumor cells added significantly to the prediction of overall survival provided by other known prognostic factors among the patients with blood type A or AB (P = 0.004). CONCLUSIONS. Expression of blood-group antigen A in tumor cells is an important favorable prognostic factor in patients with non-small-cell lung cancer. This variable needs to be considered in the design of future trials of therapy.
Source Information
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
This article has been cited by other articles:
Tsuboi, K., Asao, T., Ide, M., Hashimoto, S., Noguchi, K., Kominato, Y., Saniabadi, A. R., Kuwano, H., Yazawa, S.
(2007). {alpha}1,2Fucosylation Is a Superior Predictor of Postoperative Prognosis for Colorectal Cancer Compared with Blood Group A, B, or Sialyl Lewis X Antigen Generated within Colorectal Tumor Tissues. Ann. Surg. Oncol.
14: 1880-1889
[Abstract][Full Text]
Sanchez-Mora, N., Cebollero Presmanes, M., Monroy, V., Herranz Aladro, M., Alvarez-Fernandez, E.
(2007). Expression of histo-blood group antigens in bronchial squamous metaplasia. Eur Respir J
29: 268-272
[Abstract][Full Text]
Onn, A., Choe, D. H., Herbst, R. S., Correa, A. M., Munden, R. F., Truong, M. T., Vaporciyan, A. A., Isobe, T., Gilcrease, M. Z., Marom, E. M.
(2005). Tumor Cavitation in Stage I Non-Small Cell Lung Cancer: Epidermal Growth Factor Receptor Expression and Prediction of Poor Outcome. Radiology
237: 342-347
[Abstract][Full Text]
Onn, A., Correa, A. M., Gilcrease, M., Isobe, T., Massarelli, E., Bucana, C. D., O'Reilly, M. S., Hong, W. K., Fidler, I. J., Putnam, J. B., Herbst, R. S.
(2004). Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer. Clin. Cancer Res.
10: 136-143
[Abstract][Full Text]
Becker, D. J., Lowe, J. B.
(2003). Fucose: biosynthesis and biological function in mammals. Glycobiology
13: 41R-53R
[Abstract][Full Text]
Kominato, Y., Hata, Y., Takizawa, H., Matsumoto, K., Yasui, K., Tsukada, J.-i., Yamamoto, F.-i.
(2002). Alternative Promoter Identified between a Hypermethylated Upstream Region of Repetitive Elements and a CpG Island in Human ABO Histo-blood Group Genes. J. Biol. Chem.
277: 37936-37948
[Abstract][Full Text]
Brundage, M. D., Davies, D., Mackillop, W. J.
(2002). Prognostic Factors in Non-small Cell Lung Cancer* : A Decade of Progress. Chest
122: 1037-1057
[Abstract][Full Text]
Bepler, G., Gautam, A., McIntyre, L. M., Beck, A. F., Chervinsky, D. S., Kim, Y.-C., Pitterle, D. M., Hyland, A.
(2002). Prognostic Significance of Molecular Genetic Aberrations on Chromosome Segment 11p15.5 in Non-Small-Cell Lung Cancer. JCO
20: 1353-1360
[Abstract][Full Text]
Bianco, T., Farmer, B. J., Sage, R. E., Dobrovic, A.
(2001). Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood
97: 3633-3639
[Abstract][Full Text]
Khuri, F. R., Wu, H., Lee, J. J., Kemp, B. L., Lotan, R., Lippman, S. M., Feng, L., Hong, W. K., Xu, X.-C.
(2001). Cyclooxygenase-2 Overexpression Is a Marker of Poor Prognosis in Stage I Non-Small Cell Lung Cancer. Clin. Cancer Res.
7: 861-867
[Abstract][Full Text]
Khuri, F. R., Lotan, R., Kemp, B. L., Lippman, S. M., Wu, H., Feng, L., Lee, J. J., Cooksley, C. S., Parr, B., Chang, E., Walsh, G. L., Lee, J. S., Hong, W. K., Xu, X.-C.
(2000). Retinoic Acid Receptor-Beta as a Prognostic Indicator in Stage I Non-Small-Cell Lung Cancer. JCO
18: 2798-2804
[Abstract][Full Text]
Herbst, R. S., Yano, S., Kuniyasu, H., Khuri, F. R., Bucana, C. D., Guo, F., Liu, D., Kemp, B., Lee, J. J., Hong, W. K., Fidler, I. J.
(2000). Differential Expression of E-cadherin and Type IV Collagenase Genes Predicts Outcome in Patients with Stage I Non-Small Cell Lung Carcinoma. Clin. Cancer Res.
6: 790-797
[Abstract][Full Text]
Moldvay, J., Scheid, P., Wild, P., Nabil, K., Siat, J., Borrelly, J., Marie, B., Farré, G., Labib, T., Pottier, G., Sesboüé, R., Bronner, C., Vignaud, J.-M., Martinet, Y., Martinet, N.
(2000). Predictive Survival Markers in Patients with Surgically Resected Non-Small Cell Lung Carcinoma. Clin. Cancer Res.
6: 1125-1134
[Abstract][Full Text]
Kominato, Y., Hata, Y., Takizawa, H., Tsuchiya, T., Tsukada, J., Yamamoto, F.-i.
(1999). Expression of Human Histo-blood Group ABO Genes Is Dependent upon DNA Methylation of the Promoter Region. J. Biol. Chem.
274: 37240-37250
[Abstract][Full Text]
Graziano, S. L., Gamble, G. P., Newman, N. B., Abbott, L. Z., Rooney, M., Mookherjee, S., Lamb, M. L., Kohman, L. J., Poiesz, B. J.
(1999). Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer. JCO
17: 668-668
[Abstract][Full Text]
GREATENS, T. M., NIEHANS, G. A., RUBINS, J. B., JESSURUN, J., KRATZKE, R. A., MADDAUS, M. A., NIEWOEHNER, D. E.
(1998). Do Molecular Markers Predict Survival in Non-Small-Cell Lung Cancer?. Am. J. Respir. Crit. Care Med.
157: 1093-1097
[Abstract][Full Text]
Kominato, Y., Tsuchiya, T., Hata, N., Takizawa, H., Yamamoto, F.-i.
(1997). Transcription of Human ABO Histo-blood Group Genes Is Dependent upon Binding of Transcription Factor CBF/NF-Y to Minisatellite Sequence. J. Biol. Chem.
272: 25890-25898
[Abstract][Full Text]
Nesbitt, J. C., Putnam, J. B. Jr, Walsh, G. L., Roth, J. A., Mountain, C. F.
(1995). Survival in Early-Stage Non--Small Cell Lung Cancer. Ann. Thorac. Surg.
60: 466-472
[Abstract][Full Text]
Dresler, C. M., Ritter, J. H., Wick, M. R., Roper, C. L., Patterson, G. A., Cooper, J. D.
(1995). Immunostains for Blood Group Antigens Lack Prognostic Significance in T1 Lung Carcinoma. Ann. Thorac. Surg.
59: 1069-1073
[Abstract][Full Text]
Rice, T. W., Tubbs, R. R., Hoeltge, G. A., Kirby, T. J., Meeker, D. P., Medendorp, S. V., Bukowski, R. M.
(1995). Expression of Blood Group Antigen A by Stage I Non-Small Cell Lung Carcinomas. Ann. Thorac. Surg.
59: 568-572
[Abstract][Full Text]
Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., Mason, D. Y.
(1993). bcl-2 Protein in Non-Small-Cell Lung Carcinoma. NEJM
329: 690-694
[Abstract][Full Text]
Previous
